Synthesis and Agonist Activity of Cyclic ADP-ribose Analogues with Substitution of the Northern Ribose by Ether or Alkane Chains.

Jianfeng Xu,Zhenjun Yang,Werner Dammermann,Liangren Zhang,Andreas H. Guse,Li-he Zhang
DOI: https://doi.org/10.1021/jm060320e
IF: 8.039
2006-01-01
Journal of Medicinal Chemistry
Abstract:Novel analogues of cADPR with adenine as base and ether (10a) or different alkane chain (10b-d) substitutions of the northern ribose were synthesized from protected imidazole nucleoside 1 in good yields. The pharmacological activities of cyclic inosine diphosphoribose ether (cIDPRE) and the compounds (10a-d) were analyzed in intact human Jurkat T-lymphocytes. The results indicate that the analogues 10a-d permeate the plasma membrane and are weak agonists of the cADPR/ryanodine receptor signaling system in intact human Jurkat T cells. They are the first membrane-permeant and biologically active cADPR analogues that contain ether or alkane bridges instead of the northern ribose and retain adenine as its base.
What problem does this paper attempt to address?